Serial Number
98030463
Owner
DAY ONE BIOPHARMACEUTICALS, INC.Attorney
Connie L. EllerbachFirst Use Date
May 6, 2024
Filing Date
Jun 6, 2023
OJEMDA Trademark
Serial Number: 98030463 • Registration: 7871167
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
1800 Sierra Point Parkway, Suite 200
Brisbane, CA 94005
Entity Type: 03
Legal Representation
Correspondence Address
Connie L. Ellerbach FENWICK & WEST LLP
801 CALIFORNIA STREET
SILICON VALLEY CENTER
MOUNTAIN VIEW, CA 94041
United States
Trademark Details
Filing Date
June 6, 2023
Registration Date
July 22, 2025
First Use Anywhere
May 6, 2024
First Use in Commerce
May 6, 2024
Published for Opposition
July 9, 2024
Goods & Services
Pharmaceutical preparations for human use for the treatment of cancer; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of oncological diseases and disorders; targeted pharmaceutical preparations for use in the field of cancer prevention and treatment; pharmaceutical preparations for the delivery of compounds to the body for the treatment and prevention of oncological related diseases and disorders
Medical information services; healthcare services, namely, providing cancer treatment information to physicians, health care professionals, and patients; medical information services, namely, providing information regarding oncological diseases and disorders
Research, development, and product evaluation of pharmaceutical preparations for the prevention and treatment of cancer; laboratory analysis and research of drugs and pharmaceutical products; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; design, development, research, and testing of new products, namely, drugs and pharmaceuticals for the treatment and/or prevention of oncological diseases and disorders
